We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH Pressured to Keep CAR-T Therapy Affordable Before Granting License
NIH Pressured to Keep CAR-T Therapy Affordable Before Granting License
Advocacy groups are urging the National Institutes of Health (NIH) to keep a lid on the price of a CAR-T therapy if it decides to give an exclusive license to a group of former venture capital firm members.